Company / CapEx per Share
Oruka Therapeutics, Inc. CapEx per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.01
FY2024
5-year range
$0.00 / $0.01
FY2020-FY2024
Trend
-
vs FY2023
Sector context
#121 of 192
Health Care
What the data says
At $0.01, Oruka Therapeutics, Inc.'s capex per share ranks #121 of 192 in the Health Care sector. CapEx per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2023 to $0.01 in FY2024.
Based on SEC 10-K filings.
0.01 in FY2024 with a 5-year CAGR of +16.8%.
Improved from $0.00 to $0.01 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +78.2%
- 5-Year CAGR
- +16.8%
- 10-Year CAGR
- -
Sector benchmark
#121 of 192 in Health CareTop 63% of 192This company $0.01 Sector average $2.46
▼
-99.5% below sector average
Key checks
Key Insights
- Ranks #121 out of 192 companies in the Health Care sector.
- Lowest capex per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.01 | - |
| FY2023 | $0.00 | -100.0% |
| FY2022 | $0.00 | +50.0% |
| FY2021 | $0.00 | -20.7% |
| FY2020 | $0.00 | -51.5% |
| FY2019 | $0.01 | +1929.6% |
| FY2018 | $0.00 | -80.7% |
| FY2017 | $0.00 | +8.7% |
| FY2016 | $0.00 | -80.7% |
| FY2015 | $0.01 | +208.2% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026